(Q43715274)

26 November 2017

title

SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum (English)

1 reference

26 November 2017

1 reference

Pintor A

1

1 reference

26 November 2017

Quarta D

2

1 reference

26 November 2017

Pèzzola A

3

1 reference

26 November 2017

Reggio R

4

1 reference

26 November 2017

Popoli P

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

421

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

177-180

1 reference

Brain Adenosine Receptors as Targets for Therapeutic Intervention in Neurodegenerative Diseases

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Excitotoxicity in neurological disorders--the glutamate paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Adenosine A2A receptors and neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Glutamate release in severe brain ischaemia is mainly by reversed uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Evidence that A(2a) and not A(2b) purinoceptors are coupled to production of nitric oxide in the central regulation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901058-5

10.1016/S0014-2999(01)01058-5

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference